TABLE 1

Characteristics and Radionuclide Imaging Results of 57 Patients

Patient no.Age (y)SexHistologic typeSize (cm)pStageFDG SUVRecurrenceInterval* (mo)StatusInterval (mo)
170FBAC1.2IA0.4514Alive14
251FBAC1.2IA0.3863Alive63
360FBAC1.6IA1.8519Alive19
469FBAC1.9IA0.6833Alive33
576FBAC2.0IA1.3231Alive31
659MBAC2.2IA1.2025Alive25
754FBAC2.2IA0.8455Alive55
849FBAC2.5IA1.0362Alive62
950FBAC2.6IA1.1051Alive51
1066MBAC2.6IA0.938Alive8
1173FBAC2.8IA2.317Alive7
1263FBAC3.8IB2.7837Alive37
1367MBAC4.0IB2.1434Alive34
1466FWell-diff. AC1.0IA2.4180Alive80
1568MWell-diff. AC1.4IIIA3.8638Alive38
1651MWell-diff. AC1.7IA2.03+14Deceased15
1746FWell-diff. AC1.9IA2.3272Alive72
1878FWell-diff. AC2.0IA1.2123Alive23
1948FWell-diff. AC2.0IA1.7831Alive31
2062FWell-diff. AC2.0IA1.2418Alive18
2149MWell-diff. AC2.4IA1.7052Alive52
2265FWell-diff. AC2.6IA1.9118Alive18
2364FWell-diff. AC3.0IA3.252Alive2
2467FWell-diff. AC3.1IB3.7128Alive28
2570MWell-diff. AC3.2IB4.4138Alive38
2665MWell- to mod. diff. AC2.8IA1.7916Alive16
2742FMod. diff. AC1.5IA2.6479Alive79
2847FMod. diff. AC1.6IA2.0451Alive51
2963MMod. diff. AC1.8IA3.8152Alive52
3074MMod. diff. AC1.8IA2.52+2Deceased4
3176FMod. diff. AC1.9IA3.7656Alive56
3271MMod. diff. AC2.1IA2.0712Alive12
3353FMod. diff. AC2.5IIIA5.31+28Deceased44
3472MMod. diff. AC2.8IA2.35+48Alive48
3553MMod. diff. AC2.9IA5.76+27Deceased32
3672FMod. diff. AC3.0IIIA6.94+17Deceased22
3759FMod. diff. AC3.5IB2.1253Alive53
3859FMod. diff. AC3.5IIIA7.06+14Deceased19
3964MMod. diff. AC3.6IIIB5.94+21Deceased36
4068MMod. diff. AC3.8IIIA4.87+8Deceased10
4175MMod. diff. AC4.9IIB6.05+8Alive25
4285MPoorly diff. AC0.8IA2.1139Alive39
4371MPoorly diff. AC2.5IA6.13+13Alive58
4473MPoorly diff. AC2.7IIA8.0519Alive19
4550MPoorly diff. AC3.2IB5.80+30Alive36
4654MPoorly diff. AC4.0IIIA8.29+4Deceased5
4759MPoorly diff. AC5.5IB5.97+12Alive14
4871MMod. diff. SCC2.0IA5.3042Alive42
4973MMod. diff. SCC2.7IA4.197Alive7
5072MMod. diff. SCC2.8IA4.766Alive6
5176MMod. diff. SCC3.0IA7.22+27Alive65
5266MPoorly diff. SCC1.5IA4.7782Alive82
5375MPoorly diff. SCC1.7IA3.7262Alive62
5464MPoorly diff. SCC4.0IB6.192Alive2
5570MPoorly diff. SCC6.3IIIA9.74+5Deceased9
5676MAdeno-SCC3.1IIIA7.90+13Deceased36
5780FLarge cell carcinoma1.8IA3.261Alive1
  • * Time interval from date of FDG PET until recurrence or last follow-up date.

  • Time interval from date of FDG PET until death or last follow-up date.

  • pStage = pathologic stage; BAC = bronchioloalveolar carcinoma; diff. = differentiated; AC = adenocarcinoma; mod. = moderately; SCC = squamous cell carcinoma; adeno-SCC = adenosquamous cell carcinoma.